{"title":"Correction to “RNF122 Promotes Glioblastoma Growth via the JAK2/STAT3/c-Myc Signaling Axis”","authors":"","doi":"10.1111/cns.70317","DOIUrl":null,"url":null,"abstract":"<p>Xiao Q, Xue K, Li L, Zhu K, Fu R, Xiong Z, RNF122 Promotes Glioblastoma Growth via the JAK2/STAT3/c-Myc Signaling Axis, CNS Neuroscience & Therapeutics 30, (2024): e70017 10.1111/cns.70017.</p><p>In the original version of our article, there was an error in Figure 6A. Specifically, the representative image of A-172 (oeRNF122 + WP1066) cells in Figure 6A is incorrect. The correct image is provided below. This correction will not affect the results and conclusions.</p>","PeriodicalId":154,"journal":{"name":"CNS Neuroscience & Therapeutics","volume":"31 3","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cns.70317","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS Neuroscience & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cns.70317","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Xiao Q, Xue K, Li L, Zhu K, Fu R, Xiong Z, RNF122 Promotes Glioblastoma Growth via the JAK2/STAT3/c-Myc Signaling Axis, CNS Neuroscience & Therapeutics 30, (2024): e70017 10.1111/cns.70017.
In the original version of our article, there was an error in Figure 6A. Specifically, the representative image of A-172 (oeRNF122 + WP1066) cells in Figure 6A is incorrect. The correct image is provided below. This correction will not affect the results and conclusions.
期刊介绍:
CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.